Clinical Trials Browser

Completed × INDUSTRY × Panitumumab × Clear all

Colonic Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasms, Colorectal Neoplasms

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms

Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Neoplasms, Colorectal Neoplasms

Solid Tumor, Adult

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Recurrence

Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Recurrence

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Colorectal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms

Colorectal Neoplasms

Solid Tumors

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Colonic Neoplasms, Exanthema, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Kidney Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Colorectal Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Prostatic Neoplasms

Clinical Trials

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab

VALIDATE

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

PARADIGM

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)

GATTO

Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors

Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer

SAPPHIRE

APOLLON

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)

Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

Panitumumab in Children With Solid Tumors

Effect of Panitumumab on the Pharmacokinetics of Irinotecan

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

STEPP

PRECEPT

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body